To determine the relative contributions of tumor (glioma) vs immune cells in driving the differential inflammatory signatures noted in Fig. 1a, we queried single cell RNAseq data26,27 from IDH-mutant oligodendrogliomas and astrocytomas. This evidence concerns the gene IDH1 and central nervous system cancer.